Avoid common mistakes on your manuscript.
Correction to: Ther Innov Regul Sci (2022) https://doi.org/10.1007/s43441-022-00451-8
Analysis and results, paragraph 1 - the phrase “$2415 billion” should read “$2.415 billion”. The phrase “$50,671 billion” should read “$50.671 billion”. The phrase “$91,256 billion” should read “$91.256 billion”. Discussion Section, 1st paragraph, second to last sentence states: “Conversely, when public funding takes its minimum sample value and private funding takes its maximum sample value our model predicts the probability of FDA approval to be 97.3%” The value 97.3% should be 99.3%. Discussion section, 1st paragraph, 1st sentence begins: “Out study’s findings show no statistically significant relationship …”. “Out” should be “Our”. The dataset titles in Fig. 3 were reversed. The corrected Fig. 3 follows:
Funding by Highest Phase of Development Reached, for Projects not Resulting in an FDA-Approved Medicine ($US Million).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Schulthess, D., Bowen, H.P., Popovian, R. et al. Correction: The Relative Contributions of NIH and Private Sector Funding to the Approval of New Biopharmaceuticals. Ther Innov Regul Sci 57, 170–171 (2023). https://doi.org/10.1007/s43441-022-00461-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43441-022-00461-6